BRAF and colorectal carcinoma: Recently, Yun and colleagues reported that high-dose vitamin C is selectively toxic to KRAS and BRAF mutated CRC cells, proposing that vitamin C could have therapeutic applications in the treatment of these aggressive neoplasms4.